GSK525762

Overview

GSK525762 is a new drug being tested as a treatment for myeloma. It belongs to a class of drugs known as BET Inhibitors.

SparkCures ID 274
Developed By GlaxoSmithKline
Generic Name GSK525762
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.